-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 V6xFrtbjoEPq0V5xLQcU0hpljzVRNRzeL8E+hrh3N/WFzC5zIGlvobDLO4M7wkg4
 44RMQQarBlaPTG57REDmhA==

<SEC-DOCUMENT>0001263279-04-000071.txt : 20040302
<SEC-HEADER>0001263279-04-000071.hdr.sgml : 20040302
<ACCEPTANCE-DATETIME>20040302114523
ACCESSION NUMBER:		0001263279-04-000071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20040210
ITEM INFORMATION:		Changes in registrant's certifying accountant
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20040302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX MEDICAL HOLDINGS   INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-26787-D
		FILM NUMBER:		04641562

	BUSINESS ADDRESS:	
		STREET 1:		8100 SOUTH PARK WAY
		STREET 2:		SUITE A-9
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120
		BUSINESS PHONE:		(303) 703-4906

	MAIL ADDRESS:	
		STREET 1:		8100 SOUTH PARK WAY
		STREET 2:		SUITE A-9
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARIZONA VENTURES INC
		DATE OF NAME CHANGE:	20030115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHINA GLOBAL DEVELOPMENT INC
		DATE OF NAME CHANGE:	20020130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zynex.txt
<DESCRIPTION>ZYNEX MEDICAL FORM 8-K 2-10-2004
<TEXT>
                      SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C.



                                   FORM 8-K


                                CURRENT REPORT


                    Pursuant to Section 13 or 15(d) of the
                       Securities Exchange Act of 1934


                               February 10, 2004
                 ------------------------------------------------
                 Date of Report (date of earliest event reported)


                          Zynex Medical Holdings, Inc.
              ----------------------------------------------------
              Exact Name of Registrant as Specified in its Charter


          Nevada                     33-26787-D             87-0403828
- ---------------------------       ---------------     ----------------------
State or Other Jurisdiction       Commission File     IRS Employer Identifi-
      of Incorporation                 Number              cation Number



             8100 South Park Way, Suite A-9
             Littleton, Colorado                           80120
             ----------------------------------------------------
             Address of Principal Executive Offices      Zip Code


                                (303) 703-4906
                         ------------------------------
                         Registrant's Telephone Number,
                              Including Area Code


                 378 North Main, No. 124, Logan, Utah  84041
                 -------------------------------------------
                 Former Name or Former Address, if Changed
                               Since Last Report












ITEM 4.  CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT

     On February 10, 2004, we were notified by Bierwolf, Nilson & Associates,
that due to partner rotation requirements of the Sarbannes-Oxley Act, the
accounting firm would be merging with a Salt Lake City, Utah firm, Chisholm &
Associates.  The name of the new accounting firm will be Chisholm, Bierwolf &
Nilson, LLC.

     The reports of Zynex Medical Holdings, Inc., on the financial statements
as of and for the fiscal year ended September 30, 2003, did not contain an
adverse opinion or disclaimer of opinion and was not qualified or modified as
to uncertainty, audit scope, or accounting principles, except that Bierwolf,
Nilson & Associates issued an explanatory paragraph in its fiscal 2003 and
2002 reports as to Zynex Medical Holdings, Inc. ability to continue as a going
concern.

     During the years ended September 30, 2003 and 2002 and through the date
of this Current Report on Form 8-K, there were no disagreements with Bierwolf,
Nilson & Associates on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which if not
resolved to Chisholm, Bierwolf & Nilson LLC's satisfaction, would have caused
it to make reference to the subject matter in connection with its report on
the Registrant's consolidated financial statements for such years; and there
were no reportable events as defined in Item 304(a)(1)(iv)(B) of Regulation
S-B.

     On February 10, 2004, the Company engaged Chisholm, Bierwolf & Nilson,
LLC, to review its financial statements for the periods ending December 31,
2003.  During the two most recent fiscal years and through the date of this
report, the Company has not consulted with Chisholm, Bierwolf & Nilson, LLC
regarding (i) the application of accounting principles to a specified
transaction, either completed or proposed, or the type of audit opinion that
might be rendered on the Company's financial statements, and no written report
or oral advice was provided to the Company by concluding there was an
important factor to be considered by the Company in reaching a decision as to
an accounting, auditing or financial reporting issue; or (ii) any matter was
either the subject of a disagreement, as that term is defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions thereto, or a
reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation
S-K.

     Zynex Medical Holdings, Inc., has provided a copy of this disclosure to
Bierwolf, Nilson & Associates in compliance with the provisions of Item 304
(a)(3) of Regulation S-B.  See Exhibit 16.1 Letter from Accountant's Firm to
the Securities and Exchange Commission dated March 1, 2004.

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

     (c)  Exhibits

          Exhibit 16     Letter from Bierwolf, Nilson & Associates






                                      2




                                  SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.

                                     ZYNEX MEDICAL HOLDINGS, INC.



Dated: March 2, 2004                 By:/s/ Thomas Sandgaard
                                        Thomas Sandgaard, President









































                                      3

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16
<SEQUENCE>3
<FILENAME>ex16.txt
<DESCRIPTION>EXHIBIT 16
<TEXT>
EXHIBIT 16



                          Bierwolf, Nilson & Associates
A Partnership of          Certified Public Accountants
Professional                1453 South Major Street     Nephi J. Bierwolf, CPA
Corporations               Salt Lake City, Utah 84115      Troy Nilson, CPA






March 1, 2004

Securities and Exchange Commission
Washington, DC 20549

Re: Zynex Medical Holdings, Inc..

Gentlemen:

We have read Item 4 "CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS"
contained in Zynex Medical Holdings, Inc.'s 8-K and are in agreement
with the statements contained therein, as they relate to our firm.



Very truly yours,


/s/ Bierwolf, Nilson & Associates
Bierwolf, Nilson & Associates
Salt Lake City, Utah

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
